| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Common Stock, $.01 Par Value | Award | $0 | +49,437 | +41% | $0.000000 | 170,783 | 28 Feb 2025 | Direct | F1, F2 |
| transaction | CI | Common Stock, $.01 Par Value | Award | $0 | +11,117 | +6.5% | $0.000000 | 181,900 | 28 Feb 2025 | Direct | F3 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | $1,436,319 | -4,696 | -2.6% | $305.86 | 177,204 | 28 Feb 2025 | Direct | F4 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | $7,007,253 | -22,910 | -13% | $305.86 | 154,294 | 28 Feb 2025 | Direct | F5 |
| transaction | CI | Common Stock, $.01 Par Value | Sale | $8,173,499 | -26,527 | -17% | $308.12 | 127,767 | 03 Mar 2025 | Direct | F6 |
| holding | CI | Common Stock, $.01 Par Value | 1,757 | 28 Feb 2025 | By 401(k) | F7 | |||||
| holding | CI | Common Stock, $.01 Par Value | 334,387 | 28 Feb 2025 | By GRAT | F2 | |||||
| holding | CI | Common Stock, $.01 Par Value | 153,801 | 28 Feb 2025 | By Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Employee Stock Option (Right to Buy) | Award | $0 | +39,476 | $0.000000 | 39,476 | 28 Feb 2025 | Common Stock, $.01 Par Value | 39,476 | $305.86 | Direct | F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| F2 | Reflects the transfer by the Reporting Person of 334,387 shares of common stock on May 8, 2024 to the Reporting Person's grantor retained annuity trust. In addition, it reflects the transfer by the Reporting Person's grantor retained annuity trust of 99,918 shares of common stock on January 27, 2025 in respect of a payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust. |
| F3 | These restricted shares vest in three equal annual installments beginning March 1, 2026. |
| F4 | Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| F5 | Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| F6 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2024. |
| F7 | Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan. |
| F8 | This option vests in three equal annual installments beginning March 1, 2026. |
Exhibit List: EX-24 Power of Attorney poacordani.txt